Company Description
TomoTherapy takes aim at tumors. The company develops, markets, and manufactures its TomoTherapy Hi-Art system, which is used during radiation...
Key TomoTherapy Financials
| Company Type | Public - NASDAQ (GS): TOMO Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $232.8 |
| Employees | -- |
Latest TomoTherapy Jobs jobs by Indeed
Competition
Top TomoTherapy Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
TomoTherapy Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Thomas Rockwell (Rock) Mackie | Network | E-mail |
| CEO and Director | Frederick A. (Fred) Robertson | Network | E-mail |
| President and Director | Paul J. Reckwerdt | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current TomoTherapy News
- METHOD AND INTERFACE FOR ADAPTIVE RADIATION THERAPY [European Patents] (01 Jul 2008 13:05:00 EDT)
- Two local companies suffer all-time lows [Wisconsin State Journal (Madison)] (27 Jun 2008 04:00:00 EDT)
- RaySearch and Philips enter license agreement for VMAT product [Cision (English)] (25 Jun 2008 03:24:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.